Novel therapeutic choices in immune aplastic anemia [version 1; peer review: 2 approved]
Aplastic anemia (AA) in its severe form has historically been associated with high mortality. With limited supportive care and no effective strategy to reverse marrow failure, most patients diagnosed with severe AA (SAA) died of pancytopenia complications. Since the 1970s, hematopoietic stem cell tr...
Main Author: | Phillip Scheinberg |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-09-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-1118/v1 |
Similar Items
-
Current management of severe acquired aplastic anemia
by: Phillip Scheinberg
Published: (2011-06-01) -
Aplastic Anemia
by: Prasit Chanarat, et al.
Published: (2015-02-01) -
APLASTIC ANEMIA
by: Ni Made Dharma Laksmi, et al.
Published: (2013-07-01) -
Aplastic Anemia with Ethosuximide
by: J Gordon Millichap
Published: (1994-09-01) -
Aplastic Anemia in Children
by: N.V. Nagornaya, et al.
Published: (2013-10-01)